Biovie Inc Share Price

NASDAQ: BIVI

Small Cap

$1.83

(+-0.27%)

as on September 18, 2025 at 1:29 am IST

$₹

Biovie Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's High
$1.83
Day's Price Range
$1.95
$1.83
6.56%
Upside
52 Week's Low
52 Week's High
$1.42
52-Week Price Range
$75
$1.83
22.40%
Downside
3998.36%
Upside

Biovie Inc share price movements today

Previous Close: $1.83
Open: $1.87
Volume: 587.0K
Day's Low - High: $1.83 - $1.95
52 Week Low - High: $1.42 - $75

Biovie Inc Historical Returns

1 Month Return: + 6.67 %
3 Month Return: -82.91 %
1 Year Return: -94.03 %
3 Year Return: -99.32 %
5 Year Return: 0 %

Biovie Inc Stock Fundamentals & Key Indicators

Check Biovie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.3M

EPS (TTM)

-11.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-17.8M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

19616400.00%

Biovie Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biovie Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Biovie Inc	SELL	$13.3M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Biovie Inc Stock including INR - Dollar returns

The Biovie Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Biovie Inc investment value today

Current value as on today

₹10,802

Returns

₹89,198

(-89.2%)

Returns from Biovie Inc Stock

₹93,797 (-93.8%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Biovie Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Biovie Inc. Average target price of $12

Biovie Inc Share Price Target

Get share price movements and forecasts by analysts on Biovie Inc.

What analysts predicted

84.75%UPSIDE

Target Price

$12

Current Price

$1.83

Analyzed by

6 Analysts

Target

$12.00

Biovie Inc target price $12, a slight upside of 84.75% compared to current price of $1.83. According to 6 analysts rating.

Biovie Inc Stock's Interest Amongst Investors

Search interest for Biovie Inc Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-18% versus previous 30 day period

Biovie Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	-229,376
Operating Income	-13	-10	-10	-8	-7	-4	-4	-7	-2	-18,066,185
EBITDA	-13	-7	-9	-7	-7	-4	-3	-6	-2	-3
Interest Expense	1	1	1	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-15	-9	-10	-8	-8	-4	-4	-7	-2	-17,911,570
Income Tax Expense	0	1	1	0	0	0	-4	-7	-	7
Net Income	-15	-9	-10	-8	-8	-4	-4	-7	-2	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Biovie Inc Annual Profit & Loss

All numbers in Millions USD

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	-229,377
Operating Income	0	-1	-2	-2	-2	-138	-27	-45	-32	-18,066,200
EBITDA	0	-1	-2	-2	-2	-129	-26	-44	-31	-18,066,200
Interest Expense	0	0	0	0	4	0	2	4	2	332,720
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	0	-1	-2	-2	-16	-130	-26	-50	-32	-17,911,585
Income Tax Expense	0	0	0	0	4	0	-3	4	0	-
Net Income	0	-1	-2	-2	-16	-130	-26	-50	-32	-17,911,585
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Biovie Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-9	-10	-8	-8	-4	-4	-7	-2	-17,542,105
Operating Cash Flow	-11	-12	-5	-5	-4	-3	-8	-1	-19,025,191
Investing Cash Flow	-1	14	-	-	-	-	-	-	-
Financing Cash Flow	1	0	4	15	-2	0	12	-	12,725,941
Change in Cash	-11	1	0	10	-6	-3	4	-1	17,544,523

Biovie Inc Annual Cash Flow

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-1	-2	-2	-16	-130	-26	-50	-32	-17,542,120
Operating Cash Flow	0	0	-2	-1	-10	-18	-40	-27	-19,025,205
Investing Cash Flow	-	-	-	-14	-14	-14	-14	14	-
Financing Cash Flow	0	0	2	1	14	33	55	17	12,725,954
Change in Cash	0	0	0	0	4	14	0	4	-6,299,251

Global Institutional Holdings in Biovie Inc

Funds	Holdings
Vanguard Group Inc	2.89%
Geode Capital Management, LLC	0.74%
Goss Wealth Management LLC	0.29%
UBS Group AG	0.27%
SMH Capital Inc.	0.22%

See all

Insights on Biovie Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 215.8%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 161.9%
NEGATIVE IMPACT
Price Dip
In the last 3 months, BIVI stock has moved down by -82.2%

About Biovie Inc

biovie inc. (otc pink: bivi) is developing novel drug therapies for life-threatening complications of chronic liver disease. our initial target is ascites, which can occur in patients with advanced cirrhosis due to hepatitis, nash (non-alcoholic steatohepatitis), or alcoholism. ascites affects about 100,000 americans and carries an estimated 40% mortality rate within two years of being diagnosed. the company’s new drug candidate biv201 is about to enter a phase 2 clinical trial in the us. it’s based on a drug (terlipressin) not yet available in the us, but approved in about 40 countries for treating related complications of liver cirrhosis. the fda has never approved a drug to treat ascites and there is a significant unmet medical need for our novel therapy, which has orphan drug status. biovie has attracted funding from strategic investors including aspire capital, cuong do, the global strategy lead for samsung, and hari kumar, founder of adheron therapeutics which he sold to roche fo

Organisation	Biovie Inc
Headquarters	680 W. Nye Lane, Carson City, NV, United States, 89703
Industry	Biotechnology
CEO	Mr. Cuong Viet Do M.B.A.
E-voting on shares	Click here to vote

Key Management of Biovie Inc

Name	Title
Mr. David Morse	Senior VP & Chief Regulatory Officer
Mr. Cuong Viet Do M.B.A.	President, CEO & Director
Ms. Joanne Wendy Kim CPA	CFO, Treasurer & Corporate Secretary
Dr. Joseph M. Palumbo M.D.	Executive VP of R&D and Chief Medical Officer
Mr. Clarence N. Ahlem	Senior Vice President of Operations
Dr. Penelope Markham Ph.D.	Senior Vice President of Liver Disease Program
Ms. Denise Smith	Senior Vice President of Manufacturing & Development
Dr. Christopher L. Reading Ph.D.	Senior Vice President of Alzheimer's Disease Program

FAQs

What is Biovie Inc share price today?

Biovie Inc share price today is $1.83 as on September 18, 2025 at 1:29 am IST at the close of the market. Biovie Inc share today touched a day high of $1.95 and a low of $1.83.

What is the 52 week high and 52 week low for Biovie Inc share?

Biovie Inc share touched a 52 week high of $75 on October 21, 2024 and a 52 week low of $1.42 on August 29, 2025. Biovie Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $1.83,which is 97.56% down from its 52 week high and 28.87% up from its 52 week low.

What is Biovie Inc's market capitalisation today?

Biovie Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Biovie Inc Stock (BIVI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Biovie Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biovie Inc Shares that will get you 0.8197 shares as per Biovie Inc share price of $1.83 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Biovie Inc Stock (BIVI) from India?

Indian investors can start investing in Biovie Inc (BIVI) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 2:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Biovie Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 2:39 am IST). Based on Biovie Inc share’s latest price of $1.83 as on September 18, 2025 at 1:29 am IST, you will get 5.4645 shares of Biovie Inc. Learn more about fractional shares .